{"id":55058,"date":"2023-03-21T22:04:48","date_gmt":"2023-03-21T21:04:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/"},"modified":"2023-03-21T22:04:48","modified_gmt":"2023-03-21T21:04:48","slug":"prothena-to-participate-in-stifel-2023-virtual-cns-days","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/","title":{"rendered":"Prothena to Participate in Stifel 2023 Virtual CNS Days"},"content":{"rendered":"
\n

DUBLIN, Ireland–(BUSINESS WIRE)–$PRTA<\/a> #prothena<\/a>–Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the Stifel 2023 Virtual CNS Days on Tuesday March 28, 2023 at 10:30 AM ET.\n<\/p>\n

<\/a><\/p>\n

\nA live webcast of the fireside chat can be accessed through the investor relations section of the Company’s website at www.prothena.com<\/a>. Following the live presentation, a replay of the webcast will be available on the Company’s website for at least 90 days following the presentation date.\n<\/p>\n

\nAbout Prothena<\/b>\n<\/p>\n

\nProthena Corporation plc is a late-stage clinical biotechnology company with expertise in protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare peripheral amyloid diseases. Fueled by its deep scientific expertise built over decades of research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena\u2019s pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer\u2019s disease, Parkinson\u2019s disease and a number of other neurodegenerative diseases. For more information, please visit the Company\u2019s website at www.prothena.com<\/a> and follow the Company on Twitter @ProthenaCorp.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor and Media Contacts:<\/b>\n<\/p>\n

\nInvestors
\n
IR@prothena.com<\/a>\n<\/p>\n

\nMedia
\n
Michael Bachner, Senior Director, Corporate Communications
\n
609-664-7308, michael.bachner@prothena.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

DUBLIN, Ireland–(BUSINESS WIRE)–$PRTA #prothena–Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the Stifel 2023 Virtual CNS Days on Tuesday March 28, 2023 at 10:30 AM ET. … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55058","6":"format-standard","7":"category-industry"},"yoast_head":"\nProthena to Participate in Stifel 2023 Virtual CNS Days - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Prothena to Participate in Stifel 2023 Virtual CNS Days - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN, Ireland–(BUSINESS WIRE)–$PRTA #prothena–Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the Stifel 2023 Virtual CNS Days on Tuesday March 28, 2023 at 10:30 AM ET. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-21T21:04:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230321005737\/en\/1743693\/21\/prothena_logo_rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Prothena to Participate in Stifel 2023 Virtual CNS Days\",\"datePublished\":\"2023-03-21T21:04:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/\"},\"wordCount\":273,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005737\\\/en\\\/1743693\\\/21\\\/prothena_logo_rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/\",\"name\":\"Prothena to Participate in Stifel 2023 Virtual CNS Days - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005737\\\/en\\\/1743693\\\/21\\\/prothena_logo_rgb.jpg\",\"datePublished\":\"2023-03-21T21:04:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005737\\\/en\\\/1743693\\\/21\\\/prothena_logo_rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230321005737\\\/en\\\/1743693\\\/21\\\/prothena_logo_rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/prothena-to-participate-in-stifel-2023-virtual-cns-days\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Prothena to Participate in Stifel 2023 Virtual CNS Days\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Prothena to Participate in Stifel 2023 Virtual CNS Days - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/","og_locale":"en_US","og_type":"article","og_title":"Prothena to Participate in Stifel 2023 Virtual CNS Days - Pharma Trend","og_description":"DUBLIN, Ireland–(BUSINESS WIRE)–$PRTA #prothena–Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that members of its senior management team will participate in a fireside chat at the Stifel 2023 Virtual CNS Days on Tuesday March 28, 2023 at 10:30 AM ET. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-21T21:04:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230321005737\/en\/1743693\/21\/prothena_logo_rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Prothena to Participate in Stifel 2023 Virtual CNS Days","datePublished":"2023-03-21T21:04:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/"},"wordCount":273,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230321005737\/en\/1743693\/21\/prothena_logo_rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/","url":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/","name":"Prothena to Participate in Stifel 2023 Virtual CNS Days - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230321005737\/en\/1743693\/21\/prothena_logo_rgb.jpg","datePublished":"2023-03-21T21:04:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230321005737\/en\/1743693\/21\/prothena_logo_rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230321005737\/en\/1743693\/21\/prothena_logo_rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/prothena-to-participate-in-stifel-2023-virtual-cns-days\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Prothena to Participate in Stifel 2023 Virtual CNS Days"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55058"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55058\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}